Metagenomi (MGX) Accumulated Expenses (2023 - 2025)
Historic Accumulated Expenses for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $9.9 million.
- Metagenomi's Accumulated Expenses rose 1195.7% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 1195.7%. This contributed to the annual value of $8.4 million for FY2024, which is 2658.65% down from last year.
- Latest data reveals that Metagenomi reported Accumulated Expenses of $9.9 million as of Q3 2025, which was up 1195.7% from $5.9 million recorded in Q2 2025.
- Metagenomi's Accumulated Expenses' 5-year high stood at $11.5 million during Q4 2023, with a 5-year trough of $5.9 million in Q2 2025.
- Over the past 3 years, Metagenomi's median Accumulated Expenses value was $8.6 million (recorded in 2024), while the average stood at $8.6 million.
- Within the past 5 years, the most significant YoY rise in Metagenomi's Accumulated Expenses was 1195.7% (2025), while the steepest drop was 4606.7% (2025).
- Metagenomi's Accumulated Expenses (Quarter) stood at $11.5 million in 2023, then dropped by 26.59% to $8.4 million in 2024, then grew by 17.51% to $9.9 million in 2025.
- Its Accumulated Expenses was $9.9 million in Q3 2025, compared to $5.9 million in Q2 2025 and $6.1 million in Q1 2025.